chrX-153954240-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005334.3(HCFC1):​c.4159G>A​(p.Val1387Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,206,899 control chromosomes in the GnomAD database, including 1 homozygotes. There are 97 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1387V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00090 ( 0 hom., 30 hem., cov: 24)
Exomes 𝑓: 0.00020 ( 1 hom. 67 hem. )

Consequence

HCFC1
NM_005334.3 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.601

Publications

0 publications found
Variant links:
Genes affected
HCFC1 (HGNC:4839): (host cell factor C1) This gene is a member of the host cell factor family and encodes a protein with five Kelch repeats, a fibronectin-like motif, and six HCF repeats, each of which contains a highly specific cleavage signal. This nuclear coactivator is proteolytically cleaved at one of the six possible sites, resulting in the creation of an N-terminal chain and the corresponding C-terminal chain. The final form of this protein consists of noncovalently bound N- and C-terminal chains. The protein is involved in control of the cell cycle and transcriptional regulation during herpes simplex virus infection. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
HCFC1 Gene-Disease associations (from GenCC):
  • methylmalonic acidemia with homocystinuria, type cblX
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006447464).
BP6
Variant X-153954240-C-T is Benign according to our data. Variant chrX-153954240-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377326.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 30 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCFC1NM_005334.3 linkc.4159G>A p.Val1387Met missense_variant Exon 17 of 26 ENST00000310441.12 NP_005325.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCFC1ENST00000310441.12 linkc.4159G>A p.Val1387Met missense_variant Exon 17 of 26 1 NM_005334.3 ENSP00000309555.7
HCFC1ENST00000369984.4 linkc.4159G>A p.Val1387Met missense_variant Exon 17 of 26 5 ENSP00000359001.4
HCFC1ENST00000444191.5 linkc.-120G>A upstream_gene_variant 5 ENSP00000399589.1

Frequencies

GnomAD3 genomes
AF:
0.000891
AC:
100
AN:
112190
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000373
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000367
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000151
Gnomad OTH
AF:
0.00132
GnomAD2 exomes
AF:
0.000284
AC:
50
AN:
176270
AF XY:
0.000188
show subpopulations
Gnomad AFR exome
AF:
0.00312
Gnomad AMR exome
AF:
0.000111
Gnomad ASJ exome
AF:
0.000563
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000256
Gnomad OTH exome
AF:
0.000461
GnomAD4 exome
AF:
0.000200
AC:
219
AN:
1094656
Hom.:
1
Cov.:
34
AF XY:
0.000186
AC XY:
67
AN XY:
360674
show subpopulations
African (AFR)
AF:
0.00486
AC:
128
AN:
26351
American (AMR)
AF:
0.000115
AC:
4
AN:
34908
Ashkenazi Jewish (ASJ)
AF:
0.000782
AC:
15
AN:
19181
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30150
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
53852
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39915
Middle Eastern (MID)
AF:
0.00245
AC:
10
AN:
4079
European-Non Finnish (NFE)
AF:
0.0000393
AC:
33
AN:
840261
Other (OTH)
AF:
0.000500
AC:
23
AN:
45959
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000900
AC:
101
AN:
112243
Hom.:
0
Cov.:
24
AF XY:
0.000871
AC XY:
30
AN XY:
34429
show subpopulations
African (AFR)
AF:
0.00278
AC:
86
AN:
30925
American (AMR)
AF:
0.000373
AC:
4
AN:
10734
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3548
South Asian (SAS)
AF:
0.000368
AC:
1
AN:
2720
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6136
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
214
European-Non Finnish (NFE)
AF:
0.000151
AC:
8
AN:
53098
Other (OTH)
AF:
0.00130
AC:
2
AN:
1535
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000337
Hom.:
13
Bravo
AF:
0.00117
ESP6500AA
AF:
0.00107
AC:
4
ESP6500EA
AF:
0.000302
AC:
2
ExAC
AF:
0.000322
AC:
39

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 02, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2019
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
Feb 09, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 30, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

HCFC1-related disorder Benign:1
Apr 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Methylmalonic acidemia with homocystinuria, type cblX Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.91
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
16
DANN
Benign
0.90
DEOGEN2
Benign
0.085
T;T
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.76
T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0064
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
0.60
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.060
N;N
REVEL
Benign
0.058
Sift
Benign
0.044
D;T
Sift4G
Benign
0.22
T;T
Polyphen
0.0
B;.
Vest4
0.10
MVP
0.14
MPC
0.55
ClinPred
0.0020
T
GERP RS
2.3
PromoterAI
0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.046
gMVP
0.12
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200164926; hg19: chrX-153219691; API